InvestorsHub Logo
icon url

DaysOnTheBeach

11/08/17 8:30 AM

#202932 RE: MXAMDUD #202929

NO! Short term share price of a pre-revenue clinical stage biotech company is not a measure of the market's view of management! It simply is not.

And then you throw in all manner of unsupported and ridicules charges such as "toxic", "misleading", "too large salaries", "delay", "broken promise". THAT IS ALL NONSENSE! IT'S MADE UP NONSENSE!

Unsupported, contrived, Reflexive Negativism is not going to be the winner here. To the contrary, the patient, actual, long term shareholder WILL be the winner.

Just wait...

DOTB
icon url

58nout

11/08/17 8:42 AM

#202934 RE: MXAMDUD #202929

Wrong again Max, not even close to the all time low of 13 cents.
icon url

BonelessCat

11/08/17 9:20 AM

#202940 RE: MXAMDUD #202929

All time low .10
2009 to 2012 .25-1.05
All time high ~4.90.
Current price .695 with 52 week low .63

this wouldn't be hitting all time lows if...